FRACTYL HEALTH INC (GUTS) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:GUTS • US35168W1036

0.46 USD
-0.12 (-21.35%)
At close: Jan 30, 2026
0.5 USD
+0.04 (+8.7%)
After Hours: 1/30/2026, 8:00:01 PM
Fundamental Rating

2

GUTS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. GUTS has a bad profitability rating. Also its financial health evaluation is rather negative. GUTS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year GUTS has reported negative net income.
  • In the past year GUTS has reported a negative cash flow from operations.
  • In the past 5 years GUTS always reported negative net income.
  • GUTS had a negative operating cash flow in each of the past 5 years.
GUTS Yearly Net Income VS EBIT VS OCF VS FCFGUTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • GUTS's Return On Assets of -106.94% is on the low side compared to the rest of the industry. GUTS is outperformed by 79.89% of its industry peers.
Industry RankSector Rank
ROA -106.94%
ROE N/A
ROIC N/A
ROA(3y)-97.75%
ROA(5y)-92.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GUTS Yearly ROA, ROE, ROICGUTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

  • The Gross Margin of GUTS (100.00%) is better than 100.00% of its industry peers.
  • The Profit Margin and Operating Margin are not available for GUTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GUTS Yearly Profit, Operating, Gross MarginsGUTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

3

2. Health

2.1 Basic Checks

  • GUTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GUTS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GUTS has been increased compared to 5 years ago.
  • The debt/assets ratio for GUTS has been reduced compared to a year ago.
GUTS Yearly Shares OutstandingGUTS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
GUTS Yearly Total Debt VS Total AssetsGUTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -8.08, we must say that GUTS is in the distress zone and has some risk of bankruptcy.
  • GUTS has a worse Altman-Z score (-8.08) than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.08
ROIC/WACCN/A
WACC10.19%
GUTS Yearly LT Debt VS Equity VS FCFGUTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • A Current Ratio of 4.27 indicates that GUTS has no problem at all paying its short term obligations.
  • GUTS's Current ratio of 4.27 is fine compared to the rest of the industry. GUTS outperforms 71.74% of its industry peers.
  • A Quick Ratio of 4.27 indicates that GUTS has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 4.27, GUTS is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.27
Quick Ratio 4.27
GUTS Yearly Current Assets VS Current LiabilitesGUTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

  • The earnings per share for GUTS have decreased strongly by -59.13% in the last year.
  • Looking at the last year, GUTS shows a very negative growth in Revenue. The Revenue has decreased by -96.91% in the last year.
EPS 1Y (TTM)-59.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.92%
Revenue 1Y (TTM)-96.91%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • GUTS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.23% yearly.
  • GUTS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 450.37% yearly.
EPS Next Y-8.67%
EPS Next 2Y24.1%
EPS Next 3Y16.14%
EPS Next 5Y15.23%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y664.32%
Revenue Next 5Y450.37%

3.3 Evolution

GUTS Yearly Revenue VS EstimatesGUTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2029 2030 100M 200M 300M 400M
GUTS Yearly EPS VS EstimatesGUTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GUTS. In the last year negative earnings were reported.
  • Also next year GUTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GUTS Price Earnings VS Forward Price EarningsGUTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GUTS Per share dataGUTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • GUTS's earnings are expected to grow with 16.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.1%
EPS Next 3Y16.14%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for GUTS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

FRACTYL HEALTH INC / GUTS FAQ

What is the fundamental rating for GUTS stock?

ChartMill assigns a fundamental rating of 2 / 10 to GUTS.


What is the valuation status for GUTS stock?

ChartMill assigns a valuation rating of 0 / 10 to FRACTYL HEALTH INC (GUTS). This can be considered as Overvalued.


What is the profitability of GUTS stock?

FRACTYL HEALTH INC (GUTS) has a profitability rating of 1 / 10.


What is the financial health of FRACTYL HEALTH INC (GUTS) stock?

The financial health rating of FRACTYL HEALTH INC (GUTS) is 3 / 10.


What is the earnings growth outlook for FRACTYL HEALTH INC?

The Earnings per Share (EPS) of FRACTYL HEALTH INC (GUTS) is expected to decline by -8.67% in the next year.